Results 71 to 80 of about 44,008 (229)
The Iraqi Journal of Medical SciencesBackground: Visual impairment in diabetic retinopathy (DR) due to diabetic macular edema (DME) is common and disabling for increasing diabetic population all over the world.
Hind A. Mahdi
doaj +6 more sources
Pakistan Armed Forces Medical Journal, 2021 Objective: To investigate the effect of unilateral intravitreal Bevacizumab on contralateral eye in bilateral diabetic macular edema. Study Design: Quasi-experimental study.
Aziz Jan Bashir +5 more
doaj
Investigation of adaptive optics imaging biomarkers for detecting pathological changes of the cone mosaic in patients with type 1 diabetes mellitus [PDF]
, 2016 Purpose To investigate a set of adaptive optics (AO) imaging biomarkers for the assessment of changes of the cone mosaic spatial arrangement in patients with type 1 diabetes mellitus (DM1).
Giannini, Daniela +5 more
core +4 more sources
Combined therapy for diabetic macular edema
Middle East African Journal of Ophthalmology, 2013 Diabetic macular edema (DME) is the main cause of visual impairment in diabetic patients. Macular edema within 1 disk diameter of the fovea is present in 9% of the diabetic population. The management of DME is complex and often multiple treatment approaches are needed. This review demonstrates the benefits of intravitreal triamcinolone, bevacizumab and
Al Rashaed, Saba, Arevalo, J. Fernando
openaire +3 more sources
Acta Ophthalmologica, EarlyView.Abstract Purpose The prevalence of diabetic retinopathy (DR) is low in Greenland. Factors underlying the low prevalence may potentially protect against the development of DR. Comparing Greenlandic and Danish populations, this register‐based study explored differences in risk factors that may explain differences in DR prevalence.
Jonas Bjørn Skjøth +4 more
wiley +1 more source
Novel imaging biomarkers in diabetic retinopathy and diabetic macular edema
Therapeutic Advances in Ophthalmology, 2020 Diabetic retinopathy is one of the major microvascular complications of diabetes mellitus. The most common causes of vision loss in diabetic retinopathy are diabetic macular edema and proliferative diabetic retinopathy.
Ashish Markan +5 more
doaj +1 more source
Current Concepts in Diabetic Retinopathy [PDF]
Diabetes & Metabolism Journal, 2014 For the past several decades, tremendous efforts have been made to decrease the complications of diabetes, including diabetic retinopathy. New diagnostic modalities like ultrawide field fundus fluorescein angiography and spectral domain optical coherence
Su Jeong Song, Tien Yin Wong
doaj +1 more source
Diagnosing and monitoring diabetic macular edema: structural and functional tests. [PDF]
, 2015 Diabetic macular edema remains a major cause of visual impairment in adults despite the use of intensive glycemic control, photocoagulation therapy and new intravitreal drugs in the treatment of this disease.
Midena, Edoardo, Vujosevic, Stela
core +1 more source
Acta Ophthalmologica, EarlyView.Abstract The global demand for intravitreal anti‐vascular endothelial growth factor (anti‐VEGF) therapy continues to rise, straining ophthalmic capacity worldwide. Task shifting from physicians to trained non‐physician healthcare professionals has emerged as a potential strategy to expand service delivery.
Trang Truong Laursen +4 more
wiley +1 more source
Functional deficits precede structural lesions in mice with high-fat diet-induced diabetic retinopathy [PDF]
, 2016 Obesity predisposes to human type 2 diabetes, the most common cause of diabetic retinopathy. To determine if high-fat diet–induced diabetes in mice can model retinal disease, we weaned mice to chow or a high-fat diet and tested the hypothesis that diet ...
Bligard, Gregory W +5 more
core +2 more sources